Caris Life Sciences (CAI) Debt Ratio (2024 - 2026)

Caris Life Sciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.33 for Q1 2026.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.33 in Q1 2026; TTM through Mar 2026 was 0.33, a N/A change from a year earlier, with the FY2025 full-year figure at 0.34, down 73.29% from the prior year.
• Debt Ratio declined to 0.33 in Q1 2026 per CAI's latest filing, from 0.34 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.26 in Q4 2024 and bottomed at 0.33 in Q1 2026.
• The 3-year median for Debt Ratio is 0.38 (2025), against an average of 0.54.
• Biggest YoY gain for Debt Ratio was 73.29% in 2025; the steepest drop was 73.29% in 2025.
• Year by year, Debt Ratio stood at 1.26 in 2024, then sank by 73.29% to 0.34 in 2025, then dropped by 2.58% to 0.33 in 2026.
• Per Business Quant, the three latest CAI Debt Ratio figures stand at 0.33 (Q1 2026), 0.34 (Q4 2025), and 0.38 (Q3 2025).